Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Enikö, Sonkoly"'
Autor:
William Tillett, Alexander Egeberg, Enikö Sonkoly, Patricia Gorecki, Anna Tjärnlund, Jozefien Buyze, Sven Wegner, Dennis McGonagle
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Background Nail psoriasis is a common, physiologically, and psychologically disruptive, and yet often under-treated manifestation of psoriasis. The objectives of this analysis were to investigate the trajectory of nail psoriasis, a risk fact
Externí odkaz:
https://doaj.org/article/1656e3c7c23f4285b1babbaa95118c66
Autor:
Enikö Sonkoly, Julia-Tatjana Maul, Matteo Megna, Patricia Gorecki, Edmée Crombag, Jozefien Buyze, Laura Savage
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Scalp psoriasis affects approximately 80% of patients with psoriasis and can negatively impact their quality of life. This post hoc analysis of the VOYAGE 2 Phase III randomized clinical trial evaluated scalp response to guselkumab treatment and its
Externí odkaz:
https://doaj.org/article/4d15755484c244eeaa9d461e23f29d97
Autor:
Chen Li, Chengxi Sun, Warangkana Lohcharoenkal, Mohamad Moustafa Ali, Pengwei Xing, Wenyi Zheng, André Görgens, Manuela O. Gustafsson, Samir EL Andaloussi, Enikö Sonkoly, Andor Pivarcsi
Publikováno v:
Cell Death Discovery, Vol 9, Iss 1, Pp 1-12 (2023)
Abstract Cutaneous squamous cell carcinoma (cSCC) is a fast-increasing cancer with metastatic potential. Extracellular vesicles (EVs) are small membrane-bound vesicles that play important roles in intercellular communication, particularly in the tumo
Externí odkaz:
https://doaj.org/article/832e44aa5da14b3eabc1c21bfb2a2a2d
Autor:
Longlong Luo, Lorenzo Pasquali, Ankit Srivastava, Jan C. Freisenhausen, Andor Pivarcsi, Enikö Sonkoly
Publikováno v:
Journal of Investigative Dermatology. 143:999-1010
Autor:
Lorenzo Pasquali, Ankit Srivastava, Florian Meisgen, Kunal Das Mahapatra, Ping Xia, Ning Xu Landén, Andor Pivarcsi, Enikö Sonkoly
Publikováno v:
Acta Dermato-Venereologica, Vol 99, Iss 2, Pp 196-205 (2018)
Psoriasis is a common immune-mediated disease resulting from altered cross-talk between keratinocytes and immune cells. Previous transcriptomic studies have identified thousands of deregulated genes in psoriasis skin; however, the transcriptomic chan
Externí odkaz:
https://doaj.org/article/12ae91a47ea441b3a3dab2da052c5b7e
Publikováno v:
Acta Dermato-Venereologica, Vol 98, Iss 8, Pp 772-775 (2018)
Tofacitinib is a Janus kinase (JAK) inhibitor, which has shown efficacy in treating psoriasis. The mode of action of tofacitinib is not completely understood but it has been thought to be mediated by the inhibition of CD4+ T-cell activation. Here, we
Externí odkaz:
https://doaj.org/article/c4395cb78ead43fd92c824490bbb4231
Autor:
Xi Li, Dongqing Li, Jakob D. Wikstrom, Andor Pivarcsi, Enikö Sonkoly, Mona Ståhle, Ning Xu Landén
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract MicroRNA (miR)-132 has been identified as a top up-regulated miRNA during skin wound healing and its inhibition impairs wound repair. In a human in vivo surgical wound model, we showed that miR-132 was induced in epidermal as well as in derm
Externí odkaz:
https://doaj.org/article/edc64160f4cc426d8b6f4e11e8a1ef43
Autor:
Ping Xia, Lorenzo Pasquali, Chenying Gao, Ankit Srivastava, Nupur Khera, Jan Cedric Freisenhausen, Longlong Luo, Einar Rosén, Anke van Lierop, Bernhard Homey, Andor Pivarcsi, Enikö Sonkoly
Publikováno v:
British Journal of Dermatology. 187:211-222
Background Psoriasis is an immune-mediated inflammatory skin disease, in which an interplay between infiltrating immune cells and keratinocytes sustains chronic skin inflammation. Interleukin (IL)-17A is a key inflammatory cytokine in psoriasis and i